Slocum, Gordon & Co’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-236
Closed -$56.7K 119
2025
Q2
$56.7K Sell
236
-16
-6% -$3.73K 0.05% 81
2025
Q1
$57.1K Buy
+252
New +$55.4K 0.04% 77
2024
Q4
Sell
-909,841
Closed -$37.8M 140
2024
Q3
$37.8M Buy
909,841
+909,589
+360,948% +$213M 15.19% 1
2024
Q2
$55.3K Sell
252
-337
-57% -$73.2K 0.04% 81
2024
Q1
$132K Hold
589
0.1% 61
2023
Q4
$129K Hold
589
0.11% 60
2023
Q3
$129K Hold
589
0.11% 63
2023
Q2
$133K Hold
589
0.1% 62
2023
Q1
$113K Hold
589
0.09% 61
2022
Q4
$109K Buy
+589
New +$104K 0.07% 61

Other funds holding STE

Slocum, Gordon & Co's STE Position: Q3 2025 in Review

Slocum, Gordon & Co sold out of Steris (STE) in Q3 2025, closing a stake of 236 shares — an estimated $56.7K sold.

Slocum, Gordon & Co first reported a position in STE in Q4 2022 and held it in 10 quarters. The position peaked at $37.8M in Q3 2024. 844 funds tracked by Wall St. Rank hold STE as of Q3 2025.

  • Slocum, Gordon & Co reported no remaining Steris position as of Q3 2025 after selling out during the quarter.
  • Slocum, Gordon & Co sold 236 Steris shares in Q3 2025, an estimated $56.7K.
  • Slocum, Gordon & Co first reported a position in Steris in Q4 2022 and held it in 10 quarters.
  • Slocum, Gordon & Co's Steris position peaked at $37.8M in Q3 2024.
  • 844 funds tracked by Wall St. Rank held Steris as of Q3 2025.

Based on Slocum, Gordon & Co's 13F filing for Q3 2025, filed 17 Oct 2025.